Logo image of 56S1.DE

SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Overview

Europe - FRA:56S1 - FR0013154002 - Common Stock

211.4 EUR
-0.2 (-0.09%)
Last: 10/27/2025, 7:00:00 PM

56S1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap20.58B
Revenue(TTM)2.95B
Net Income(TTM)264.10M
Shares97.33M
Float27.74M
52 Week High227.9
52 Week Low144.1
Yearly Dividend0.71
Dividend Yield0.33%
EPS(TTM)3.5
PE60.4
Fwd PE39.39
Earnings (Next)01-26 2026-01-26/amc
IPO1994-10-20
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


56S1.DE short term performance overview.The bars show the price performance of 56S1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

56S1.DE long term performance overview.The bars show the price performance of 56S1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of 56S1.DE is 211.4 EUR. In the past month the price increased by 21.6%. In the past year, price increased by 33.29%.

SARTORIUS STEDIM BIOTECH / 56S1 Daily stock chart

56S1.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 25.16 182.80B
DAP.DE DANAHER CORP 28.28 134.07B
LO3.DE LONZA GROUP AG-REG 37.36 43.89B
QTS.DE IQVIA HOLDINGS INC 18.99 31.81B
DIM.PA SARTORIUS STEDIM BIOTECH 59.74 20.35B
SRT3.DE SARTORIUS AG-VORZUG 51.82 17.69B
SRT.DE SARTORIUS AG 42.17 14.40B
ILU.DE ILLUMINA INC 24.03 13.18B
ESF0.DE EUROFINS SCIENTIFIC 17.53 11.49B
ERF.PA EUROFINS SCIENTIFIC 16.91 11.09B
QIA.DE QIAGEN N.V. 20.44 8.95B
1BRKR.MI BRUKER CORP 16.34 5.00B

About 56S1.DE

Company Profile

56S1 logo image Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,134 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Company Info

SARTORIUS STEDIM BIOTECH

Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex

Aubagne PACA FR

Employees: 10134

56S1 Company Website

56S1 Investor Relations

Phone: 33442845600

SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ

What does SARTORIUS STEDIM BIOTECH do?

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,134 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.


What is the stock price of SARTORIUS STEDIM BIOTECH today?

The current stock price of 56S1.DE is 211.4 EUR. The price decreased by -0.09% in the last trading session.


What is the dividend status of SARTORIUS STEDIM BIOTECH?

SARTORIUS STEDIM BIOTECH (56S1.DE) has a dividend yield of 0.33%. The yearly dividend amount is currently 0.71.


How is the ChartMill rating for SARTORIUS STEDIM BIOTECH?

56S1.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What sector and industry does SARTORIUS STEDIM BIOTECH belong to?

SARTORIUS STEDIM BIOTECH (56S1.DE) operates in the Health Care sector and the Life Sciences Tools & Services industry.


Can you provide the PE ratio for 56S1 stock?

The PE ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 60.4. This is based on the reported non-GAAP earnings per share of 3.5 and the current share price of 211.4 EUR.


Can you provide the growth outlook for SARTORIUS STEDIM BIOTECH?

The Revenue of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 9.03% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


56S1.DE Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to 56S1.DE. When comparing the yearly performance of all stocks, 56S1.DE is one of the better performing stocks in the market, outperforming 87.51% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

56S1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE. Both the profitability and the financial health of 56S1.DE get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

56S1.DE Financial Highlights

Over the last trailing twelve months 56S1.DE reported a non-GAAP Earnings per Share(EPS) of 3.5. The EPS decreased by -16.47% compared to the year before.


Industry RankSector Rank
PM (TTM) 8.96%
ROA 3.35%
ROE 6.54%
Debt/Equity 0.5
Chartmill High Growth Momentum
EPS Q2Q%153.85%
Sales Q2Q%7.67%
EPS 1Y (TTM)-16.47%
Revenue 1Y (TTM)7.72%

56S1.DE Forecast & Estimates

18 analysts have analysed 56S1.DE and the average price target is 239.46 EUR. This implies a price increase of 13.27% is expected in the next year compared to the current price of 211.4.

For the next year, analysts expect an EPS growth of 27.61% and a revenue growth 9.03% for 56S1.DE


Analysts
Analysts81.11
Price Target239.46 (13.27%)
EPS Next Y27.61%
Revenue Next Year9.03%

56S1.DE Ownership

Ownership
Inst Owners11.07%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A